McMaster University
Hamilton, Ontario, L8S 4K1, Canada
NCT Number: NCT06032156
Ketone bodies are produced by the liver during periods of food scarcity or severe carbohydrate restriction. Blood ketones are an alternative fuel source used by the brain, heart, and skeletal muscle during periods of fasting. Further, ketones bodies act as a signalling molecule that have pleiotropic effects that upregulate cellular stress-resistance pathways throughout the body.
Oral supplements containing exogenous ketones have recently become available and represent a novel tool for increasing plasma ketone bodies without the need for dietary restriction. Early evidence suggests that oral ketone supplements may enhance cerebral blood flow and improve cognition. However, the dose-dependent effects of a single ketone supplement on cerebral blood flow and cognition in young adults is currently unknown.
The purpose of this study is to characterize the effects of ingesting a high versus low dose of an oral ketone monoester on cerebral blood flow, circulating blood markers, and cognition in young adults.
As an exploratory aim, this study will investigate how oxygen uptake kinetics during submaximal exercise are impacted 2 hours after ingestion of a ketone supplement. Recent findings indicate that ketone supplementation may impair exercise performance due to the physiological stress (i.e., pH disturbances) imposed by an acute ketone dose. Delaying exercise onset by 2 hours after ingestion of a ketone supplement may enhance oxygen kinetics in a dose-dependent manner.
Looking for future studies?
Notify Me18 year–35 year
All sexes
Interventional
Not applicable
Hamilton, Ontario, L8S 4K1, Canada
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Ingestion of a low dose [R]-3-hydroxybutyl [R]-3-hydroxybutyrate (0.3 g β-OHB/kg body weight) followed by 2-hours of rest. Submaximal exercise to be performed following 2-hour resting measures.
Ingestion of a high dose [R]-3-hydroxybutyl [R]-3-hydroxybutyrate (0.6 g β-OHB/kg body weight) followed by 2-hours of rest. Submaximal exercise to be performed following 2-hour resting measures.
Ingestion of a taste-matched calorie-free placebo drink followed by 2-hours of rest. Submaximal exercise to be performed following 2-hour resting measures.
Time frame: 2-hour
Measured via duplex ultrasound of the extra-cranial arteries (internal carotid and vertebral arteries).
Time frame: 2-hour
The MST (Mnemonic Similarity Task) will be used to assess hippocampal-dependent memory and pattern separation.
Time frame: 2-hour
Venous blood samples will be obtained via intravenous catheter
Time frame: 2-hour, then following completion of submaximal exercise bout
Serum and plasma BDNF measured in venous blood samples will be obtained via intravenous catheter
Time frame: 2-hour, then during submaximal exercise (performed after 2-hour rest period)
Breath-by-breath analysis performed via metabolic cart
Time frame: 2-hour, then during submaximal exercise (performed after 2-hour rest period)
Breath-by-breath analysis performed via PowerLab Gas Analyzer (AD Instruments)
Time frame: 2-hour
Automated blood pressure cuff measurement of brachial artery pressure in mmHg.
McMaster University
Other
The Acute Effects of a High Versus Low Dose of a Ketone Monoester Supplement on Cerebral Blood Flow and Cognition
Acronym: kCBF
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06217159
Cerebral Blood Flow, Cerebrovascular Function
Hamilton, Ontario, Canada
View Trial DetailsNCT03982550
Cerebrovascular Function, Cognition Disorders
Los Angeles, California, United States
View Trial DetailsNCT03272061
Behavior, Cerebral Blood Flow
Maastricht, Netherlands
View Trial DetailsNCT07406295
Body Weight, Cerebrovascular Function
Tallahassee, Florida, United States
View Trial Details